Phase 1 Amyloid Cardiomyopathy Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis.

Transthyretin Amyloid Cardiomyopathy

Novo Nordisk A/S14 enrolled1 locationNCT07448623

Recruiting

Phase 1Phase 2

Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy

Amyloid Cardiomyopathy

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's20 enrolled1 locationNCT06634108